People · Operator
Named in public records as an officer, director or promoter · active 2013–2020 · Healthtech, Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Acutus Medical, Inc. | — | Healthtech | Series D+ | $296.3M | $69.0M | 2013 |
| NeuroPace Inc | — | Other Health Care | Series C | $208.6M | $1.5B | 2016 |
| TELA Bio, Inc. | — | Biotechnology | Series C | $104.8M | $435.1M | 2014 |
Vince Burgess at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Vince Burgess on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Christopher Smith | 1 | 15 |
| Rishi Gupta | 1 | 12 |
| Kevin Johnson | 1 | 12 |
| Nael Kassar | 1 | 11 |
| Jonathan Silverstein | 1 | 10 |
| Adele Oliva | 1 | 9 |
| Steven Hochberg | 1 | 9 |
| Greg Garfield | 1 | 8 |
| James Blair | 1 | 8 |
| Kevin Rakin | 1 | 7 |
| Scott Huennekens | 1 | 7 |
| Andrew ElBardissi | 1 | 7 |
| David Fischell | 1 | 6 |
| David Bonita | 1 | 6 |
| Renee Ryan | 1 | 6 |
| Frank Fischer | 1 | 5 |
| Adele C. Oliva | 1 | 5 |
| Benjamin Pless | 1 | 5 |
| Aditya Puri | 1 | 4 |
| Joseph Lacob | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.